Healthcare Finance Staff

Aetna is positioning itself to ride out the early storms of health reform and end up plying the new waters sustainably.

Pennsylvania's largest insurer has agreed to a broader interpretation of continuity of care provisions in a long-term accord with its main rival, while also touting what it sees as positive membership choice trends.

Not everyone who could benefit from colon cancer screening is enthusiastic about receiving the invasive "gold standard" diagnostic. It can also be expensive for insurers, unlike other options for patients.

The nation's largest laboratory company and two big insurers stand accused of creating a diagnostic monopoly that hasn't passed on savings to consumers.

A short-lived network dispute has come to a resolution. But that doesn't mean the points of contention are going away.

One of the most fractious hospital acquisition disputes in the country has come back to square one, in a potential win for payers and antitrust advocates.

The ambitious new value-based healthcare coalition, including Aetna and HCSC, is wasting no time dispersing ideas. Consensus on reform may be difficult, and the work ahead even more so.

What's up with the Health Care Transformation Task Force? In the midst of all the excitement, there are very few thoughtful observers who raise questions about the march.

When Ken Fasola was working at Humana and UnitedHealth Group in the 1990s and 2000s, the industry saw individual insurance products as "the bottom end of the food chain."

Insurers have to improve consumer education about drug formularies in exchanges, at the least, and some may even have to change their practices to meet new health reform standards.